The Assessment of Affected Factors on Cytomegalovirus and Rubella Virus Prevalence in Females in Hamadan, Iran
Abstract
Cytomegalovirus (CMV) and rubella are considered as dangerous viral infections to the fetus. The findings of this research can clear the possible progress made thus far toward prevention in this part of the country. The data of all referees to genetic center of Shahid Beheshti Hospital in Hamadan, including the rubella and CMV tests were recorded in questionnaires and analyzed by logistic regression models. Univariate and multivariate logistic regression were utilized to assess the affected factors on CMV and Rubella separately. STATA and SPSS16 statistical software were used with setting P-value as 0.05. Logistic regression analysis indicates a statistically significant relationship between CMV IgM and on occupation (P=0.045), pregnancy (P=0.03) and years of referring the patients (P<0.001). The results of multivariate logistic regression analysis showed that job was significantly affected on the CMV infection [OR (95% C.I) = 1.71(1.1-2.83)]. Univariate logistic regression showed that age (P=0.001), the residential area (P=0.03), pregnancy (P=0.03), the marital status (P=0.022) and years of referring the patients (P<0.0001) has a significant effect on rubella IgG. However, multivariate logistic regression analysis also showed that residential status (OR=1.77) and age (OR=0.63) were significantly affected on the Rubella infection. The high level of IgG positivity against rubella in females may highlight the considerable impact of increasing public vaccination in this part of Iran. Also, the current data demonstrating frequency of primary infections with CMV in females which support the conclusion that regular prenatal screening tests is justified.
Ekblad U. Biological agents and pregnancy. J Occup Environ Med 1995;37(8):962-5.
Khan NA, Kazzi SN. Yield and costs of screening growthretarded infants for torch infections. Am J Perinatol 2000;17(3):131-5.
Lagasse N, Dhooge I, Govaert P. Congenital CMVinfection and hearing loss. Acta oto-rhino-laryngologica Belgica 2000;54(4):431-6.
Griffiths PD, McLean A, Emery VC. Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine 2001;19(11-12):1356-62.
Gupta SN, Gupta NN. An outbreak of rubella in a hilly district of Kangra-Chamba, Himachal Pradesh, India, 2006. Indian J Pediatr 2009;76(7):717-23.
Minussi L , Mohrdieck R, Bercini M, et al. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil. Reprod Toxicol 2008;25(1):120-3.
Webster WS. Teratogen update: congenital rubella. Teratology 1998;58(1):13-23.
Lanzieri TM, Pinto D, Prevots DR. Impact of rubella vaccination strategy on the occurrence of congenital rubella syndrome. J Pediatr 2007;83(5):415-21.
Namaei MH, Ziaee M, Naseh N. Congenital rubella syndrome in infants of women vaccinated during or just before pregnancy with measles-rubella vaccine. Indian J Med Res 2008;127(6):551-4.
Odland JO, Sergejeva IV, Ivaneev MD, et al. Seropositivity of cytomegalovirus, parvovirus and rubella in pregnant women and recurrent aborters in Leningrad County, Russia. Acta ObstetGynecol Scand 2001;80(11):1025-9.
Ghazi HO, Telmesani AM, Mahomed MF. TORCH agents in pregnant Saudi women. Med Princ Pract 2002;11(4):180-2.
Singh MP, Arora S, Das A, et al. Congenital rubella and cytomegalovirus infections in and around Chandigarh. Indian J Pathol Microbiol 2009;52(1):46-8.
Doroudchi M, Dehaghani AS, Emad K, et al. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran. East Mediterr Health J 2001;7(1-2):128-38.
Dayan GH, Caquias CR, Garcia Y, et al. Medical practices for prevention of perinatal infections in Puerto Rico. PaediatrPerinatEpidemiol 2008;22(1):31-9.
Bamgboye AE, Afolabi KA, Esumeh FI, et al. Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria. West Afr J Med 2004;23(3):245-8.
Lo Giudice D, Cannavo G, Capua A, et al. Eliminating congenital rubella: a seroepidemiological study on women of childbearing age and MMR vaccine coverage in newborns. J Prev Med Hyg 2009;50(4):236-40.
Files | ||
Issue | Vol 52, No 4 (2014) | |
Section | Original Article(s) | |
Keywords | ||
Cytomegalovirus Rubella Epidemiology Immunology Prevention and control Iran |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |